G
Genomictree Inc
KOSDAQ:228760
Genomictree Inc
KOSDAQ:228760
Price:
22 300
KRW
2.29%
Market Cap:
₩543.7B
Balance Sheet
Balance Sheet Decomposition
Genomictree Inc
Genomictree Inc
Balance Sheet Decomposition is not available for
Genomictree Inc
Genomictree Inc
Balance Sheet
Genomictree Inc
Genomictree Inc
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
101
|
1 344
|
3 916
|
7 393
|
42 900
|
56 641
|
66 461
|
67 572
|
45 269
|
26 350
|
|
| Cash Equivalents |
101
|
1 344
|
3 916
|
7 393
|
42 900
|
56 641
|
66 461
|
67 572
|
45 269
|
26 350
|
|
| Short-Term Investments |
2 754
|
640
|
2 500
|
0
|
57 406
|
46 478
|
64 070
|
47 033
|
40 877
|
69 730
|
|
| Total Receivables |
373
|
49
|
57
|
86
|
739
|
388
|
2 878
|
1 691
|
1 115
|
918
|
|
| Accounts Receivables |
372
|
37
|
33
|
10
|
88
|
230
|
2 292
|
1 175
|
673
|
607
|
|
| Other Receivables |
1
|
12
|
24
|
76
|
651
|
158
|
585
|
516
|
442
|
311
|
|
| Inventory |
0
|
0
|
0
|
0
|
267
|
1 231
|
285
|
635
|
497
|
335
|
|
| Other Current Assets |
363
|
285
|
187
|
83
|
747
|
562
|
634
|
1 068
|
7 613
|
330
|
|
| Total Current Assets |
3 591
|
2 318
|
6 660
|
7 562
|
102 058
|
105 300
|
134 327
|
118 000
|
95 371
|
97 662
|
|
| PP&E Net |
2 583
|
2 548
|
2 813
|
5 427
|
7 535
|
10 633
|
21 459
|
17 866
|
17 460
|
18 386
|
|
| PP&E Gross |
2 583
|
2 548
|
2 813
|
5 427
|
7 535
|
10 633
|
21 459
|
17 866
|
17 460
|
18 386
|
|
| Accumulated Depreciation |
748
|
814
|
885
|
989
|
1 036
|
1 433
|
1 946
|
2 444
|
3 275
|
4 268
|
|
| Intangible Assets |
406
|
556
|
832
|
959
|
1 042
|
962
|
1 669
|
1 554
|
1 357
|
1 250
|
|
| Long-Term Investments |
147
|
75
|
75
|
0
|
3 066
|
969
|
16 963
|
20 451
|
18 377
|
13 083
|
|
| Other Long-Term Assets |
3
|
5
|
5
|
6
|
25
|
31
|
2 733
|
5 039
|
279
|
294
|
|
| Total Assets |
6 731
N/A
|
5 502
-18%
|
10 386
+89%
|
13 954
+34%
|
113 725
+715%
|
117 896
+4%
|
177 151
+50%
|
162 910
-8%
|
132 844
-18%
|
130 675
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
20
|
0
|
69
|
226
|
84
|
88
|
133
|
67
|
67
|
|
| Accrued Liabilities |
57
|
93
|
108
|
207
|
290
|
342
|
441
|
1 821
|
1 433
|
1 445
|
|
| Short-Term Debt |
500
|
500
|
506
|
500
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
285
|
277
|
29 095
|
1 737
|
2 019
|
|
| Other Current Liabilities |
470
|
334
|
224
|
274
|
948
|
3 379
|
1 336
|
22 393
|
2 045
|
1 219
|
|
| Total Current Liabilities |
1 027
|
947
|
837
|
1 051
|
1 464
|
4 090
|
2 142
|
53 442
|
5 281
|
4 751
|
|
| Long-Term Debt |
5 131
|
0
|
0
|
400
|
1 200
|
11 261
|
38 179
|
85
|
98
|
60
|
|
| Deferred Income Tax |
207
|
207
|
207
|
207
|
207
|
207
|
207
|
580
|
93
|
93
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
99
|
0
|
0
|
502
|
295
|
435
|
|
| Other Liabilities |
755
|
850
|
1 045
|
1 211
|
2 034
|
7 083
|
21 523
|
1 247
|
2 340
|
1 452
|
|
| Total Liabilities |
7 119
N/A
|
2 004
-72%
|
2 089
+4%
|
2 869
+37%
|
4 806
+68%
|
22 640
+371%
|
62 050
+174%
|
55 855
-10%
|
8 108
-85%
|
6 791
-16%
|
|
| Equity | |||||||||||
| Common Stock |
914
|
1 153
|
3 880
|
7 975
|
9 993
|
9 993
|
10 551
|
10 668
|
12 006
|
12 181
|
|
| Retained Earnings |
2 715
|
4 823
|
7 009
|
9 586
|
20 347
|
32 310
|
46 434
|
39 976
|
31 274
|
20 602
|
|
| Additional Paid In Capital |
1 413
|
7 168
|
11 426
|
12 697
|
118 518
|
118 518
|
55 819
|
57 050
|
79 972
|
85 935
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 984
|
4 984
|
4 878
|
|
| Other Equity |
0
|
0
|
0
|
0
|
755
|
946
|
2 296
|
4 345
|
6 468
|
10 045
|
|
| Total Equity |
389
N/A
|
3 498
N/A
|
8 296
+137%
|
11 085
+34%
|
108 919
+883%
|
95 255
-13%
|
115 101
+21%
|
107 055
-7%
|
124 736
+17%
|
123 885
-1%
|
|
| Total Liabilities & Equity |
6 731
N/A
|
5 502
-18%
|
10 386
+89%
|
13 954
+34%
|
113 725
+715%
|
117 896
+4%
|
177 151
+50%
|
162 910
-8%
|
132 844
-18%
|
130 675
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
11
|
14
|
16
|
16
|
20
|
20
|
20
|
21
|
24
|
24
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
